Jochem B. Buil

发表

Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013–2018

E. Kuijper, W. Melchers, J. Meis, 2020, Emerging infectious diseases.

Pharmacokinetics and Pharmacodynamics of Posaconazole

C. Knibbe, P. Verweij, E. Krekels, 2020, Drugs.

European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study.

Eelco F. J. Meijer, A. Barać, V. Arsenijevic, 2023, Journal of Infection.

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

Eelco F. J. Meijer, M. Egger, A. Barać, 2023, The Lancet. Infectious diseases.

Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance

W. Melchers, J. Zoll, P. Verweij, 2021, bioRxiv.

Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi

W. Melchers, S. de Hoog, P. Verweij, 2021, Journal of fungi.

Targeting the 16S rRNA Gene by Reverse Complement PCR Next-Generation Sequencing: Specific and Sensitive Detection and Identification of Microbes Directly in Clinical Samples

W. Melchers, H. Wertheim, S. Moorlag, 2023, Microbiology spectrum.

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Russell E. Lewis, D. D. de Lange, T. Calandra, 2021, Intensive Care Medicine.

Mycotic Infections in Free-Ranging Harbor Porpoises (Phocoena phocoena)

L. IJsseldijk, A. Gröne, E. Broens, 2020, Frontiers in Marine Science.

Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans

G. S. de Hoog, A. Al‐Hatmi, P. Verweij, 2020, Antimicrobial Agents and Chemotherapy.

Do high MICs predict the outcome in invasive fusariosis?

L. Pagano, G. Nadali, F. Farina, 2020, The Journal of antimicrobial chemotherapy.

Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients

W. Melchers, P. White, F. L. van de Veerdonk, 2021, Journal of clinical microbiology.

Fungi involved in rhinosinusitis in arid regions: insights from molecular identification and antifungal susceptibility

S. de Hoog, P. Verweij, Sarah A. Ahmed, 2023, Microbiology spectrum.

Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active Prophylaxis

C. Schaefer-Prokop, S. Schalekamp, E. D. de Kort, 2022, Journal of fungi.

High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections

R. Hoek, S. Henriet, J. Cornelissen, 2019, Mycoses.

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs

W. Melchers, J. Meis, J. Zoll, 2018, The Journal of antimicrobial chemotherapy.

The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus

B. Zwaan, W. Melchers, M. Arendrup, 2019, PLoS pathogens.

Burden of serious fungal infections in the Netherlands

Eelco F. J. Meijer, D. Denning, J. Meis, 2020, Mycoses.

A mould infection in disguise.

P. Pickkers, P. Verweij, H. V. D. van der Lee, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antifungal Resistance in Pulmonary Aspergillosis

P. Verweij, Yinggai Song, Jochem B. Buil, 2024, Seminars in Respiratory and Critical Care Medicine.

Genetic and Phenotypic Characterization of in-Host Developed Azole-Resistant Aspergillus flavus Isolates

W. Melchers, J. Meis, J. Houbraken, 2021, Journal of fungi.

In vitro activity of the novel antifungal compound F901318 against difficult‐to‐treat Aspergillus isolates

W. Melchers, J. Meis, P. Verweij, 2017, The Journal of antimicrobial chemotherapy.

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis

N. Van Regenmortel, R. Nyga, S. Nseir, 2021, Emerging infectious diseases.

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

Eelco F. J. Meijer, A. Barać, J. Meis, 2023, Mycopathologia.

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

B. Mégarbane, A. Wilmer, S. Nseir, 2021, Intensive Care Medicine.

Airway persistence by the emerging multi‐azole‐resistant Rasamsonia argillacea complex in cystic fibrosis

J. Meis, M. Fisher, J. Elborn, 2018, Mycoses.

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

E. Kuijper, W. Melchers, P. Verweij, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Diagnosis, treatment and prognosis of otomastoiditis induced by Fusobacterium necrophorum: A retrospective multicentre cohort study.

S. Bekkers, J. Buil, J. Waterval, 2022, Anaerobe.

Update on Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Identification of Filamentous Fungi

B. Posteraro, M. Sanguinetti, P. Verweij, 2020, Journal of Clinical Microbiology.